Neurizon Therapeutics Limited (ASX:NUZ)
Australia
· Delayed Price · Currency is AUD 0.0820
-0.0010 (-1.20%)
At close: Mar 6, 2026
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 57.29 million as of March 6, 2026. Its market cap has decreased by -27.27% in one year.
Market Cap
57.29M
Enterprise Value
50.96M
Revenue
5.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 57.29M, an increase of 1,269.47%. That is a compound annual growth rate of 11.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amplia Therapeutics | 56.44M |
| Proteomics International Laboratories | 53.68M |
| Entropy Neurodynamics | 53.31M |
| Prescient Therapeutics | 63.09M |
| EZZ Life Science Holdings | 51.07M |
| Radiopharm Theranostics | 74.43M |
| Avecho Biotechnology | 44.08M |
| Imugene | 75.56M |